David McElligott
Fondatore presso Ranar Therapeutics, Inc.
Profilo
David McElligott is the founder of Ranar Therapeutics, Inc. which was founded in 2021.
He is currently the Chief Scientific Officer at Accelerator Services Corp since 2012.
Dr. McElligott's former jobs include Senior Director-Drug Discovery at ICOS Corp.
from 1997 to 2011, Principal at The Salk Institute for Biological Studies, Vice President-Research & Development at Groove Biopharma Corp., and Professor at The Scripps Research Institute.
He was also the President of Borealis Biotechnology LLC from 2007 to 2008.
Dr. McElligott received his undergraduate and doctorate degrees from the University of Iowa.
Posizioni attive di David McElligott
| Società | Posizione | Inizio |
|---|---|---|
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Corporate Officer/Principal | 01/03/2012 |
Ranar Therapeutics, Inc.
 Ranar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ranar Therapeutics, Inc. is a company that specializes in manufacturing low cost screen printing equipment and resources for starting a t-shirt printing business. The company is based in Seattle, WA. The company offers silkscreening supplies for making and removing stencils on screens, plastisol ink for garments, as well as eco-friendly ink citrus cleaners. The company was founded by David McElligott. The CEO is Mike Gallatin. | Fondatore | 01/10/2021 |
Precedenti posizioni note di David McElligott
| Società | Posizione | Fine |
|---|---|---|
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Corporate Officer/Principal | 30/10/2021 |
| Borealis Biotechnology LLC | Presidente | 30/08/2008 |
| The Salk Institute for Biological Studies | Corporate Officer/Principal | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | - |
Formazione di David McElligott
| University of Iowa | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Groove Biopharma Corp.
 Groove Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Groove Biopharma Corp. focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) were involved in extensive regulatory networks for many target genes and pathways. Groove Biopharma's core technology addressed a new avenue of nucleotide therapeutic drug discovery via modulation of cellular mirna. Used exclusive technology, Groove Biopharma were generated a series of lead candidates with the potential to be best-in-class therapeutics. By incorporated proprietary structural modifications into miRNA therapeutics, the Groove Biopharma technology platform presented promising potential for treating a wide range of diseases, including cancer, fibrosis, and infectious disease.The company was founded in 2008 and is headquartered in Seattle,UN. | Commercial Services |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Ranar Therapeutics, Inc.
Ranar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ranar Therapeutics, Inc. is a company that specializes in manufacturing low cost screen printing equipment and resources for starting a t-shirt printing business. The company is based in Seattle, WA. The company offers silkscreening supplies for making and removing stencils on screens, plastisol ink for garments, as well as eco-friendly ink citrus cleaners. The company was founded by David McElligott. The CEO is Mike Gallatin. | Commercial Services |
Petra Pharma Corp.
Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Health Technology |
| Borealis Biotechnology LLC |
- Borsa valori
- Insiders
- David McElligott
